{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:48:06Z","timestamp":1791982086288,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.braindev.2026.104600","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:18:07Z","timestamp":1791217087000},"page":"104600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-CASPR2 antibody associated Morvan syndrome in adolescents: dramatic response to immunotherapy: a case series"],"prefix":"10.1016","volume":"48","author":[{"given":"Busra","family":"Aynekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"I\u015f\u0131kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2026.104600_bb0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.braindev.2026.104600_bb0010","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1007\/s00415-021-10614-6","article-title":"Pediatric LGI1 and CASPR2 autoimmunity associated with COVID-19: Morvan syndrome","volume":"268","author":"Kilic","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2026.104600_bb0015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4103\/0028-3886.349616","article-title":"Morvan\u2019s syndrome presenting with psychiatric manifestations: a case report and review of the literature","volume":"70","author":"Kumar","year":"2022","journal-title":"Neurol India"},{"key":"10.1016\/j.braindev.2026.104600_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.565694","article-title":"Differentiating oneiric stupor in agrypnia excitata from dreaming disorders","volume":"11","author":"Baldelli","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2026.104600_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2026.104600_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related Morvan syndrome: autonomic, polysomnographic, and neuropsychological observations","volume":"11","author":"Swayang","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.braindev.2026.104600_bb0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/WCO.0000000000001104","article-title":"Autoimmune neuromyotonia","volume":"35","author":"Comperat","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.braindev.2026.104600_bb0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0896-6273(00)81049-1","article-title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels","volume":"24","author":"Poliak","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.braindev.2026.104600_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells13010015","article-title":"Pathophysiological effects of autoantibodies in autoimmune encephalitides","volume":"13","author":"Ryding","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.braindev.2026.104600_bb0050","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/ene.13922","article-title":"Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study","volume":"26","author":"Gastaldi","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.braindev.2026.104600_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.813487","article-title":"Case report: anti-LGI1 encephalitis following COVID-19 vaccination","volume":"12","author":"Zlotnik","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.braindev.2026.104600_bb0060","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2026.104600_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2026.104600_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/jpn.JPN_128_19","article-title":"A rare case of peripheral nerve hyperexcitability in childhood: Isaacs syndrome","volume":"15","author":"Kanmaz","year":"2020","journal-title":"J Pediatr Neurosci"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:04:02Z","timestamp":1791979442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760426001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0387760426001014"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104600","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-CASPR2 antibody associated Morvan syndrome in adolescents: dramatic response to immunotherapy: a case series","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104600"}}